Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -8 of 8
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Title
Phase
Protocol IDs
Erlotinib and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer
Phase II, Phase I
VU-VICC-GI-0622
VICC-GI-0622, 6980, NCI-6980, NCT00397384
Evaluation of Single Session Stereotactic Body Radiotherapy
Phase II, Phase I
2005-0445
NCT00492817
Evaluation of a Novel CT-On-Rails or Trilogy Stereotactic Spine Radiotherapy System (SSRS)
Phase II, Phase I
ID02-446
NCT00508443
UCN-01 and Irinotecan in Treating Patients With Metastatic or Unresectable Solid Tumors
Phase I
WUSM-SCC-0102
NCI-5582, 5582, NCT00031681
Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer
Phase I
MAYO-MC064G
MC064G, NCT00654160
Chemoradiation-Induced Nausea and Emesis: Quality of Life
No phase specified
2003-0529
NCT00394602
Quality of Life and Functional Outcomes After Combined Modality Therapy for Anal Cancer: Conventional Versus IMRT
No phase specified
ANAL0002
e-Protocol 3103, NCT00533325
CBT-1 and Paclitaxel in Treating Patients With Refractory, Recurrent, or Advanced Metastatic Solid Tumors
No phase specified
NCI-08-C-0035
08-C-0035, NCT00658424
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute